Repair of Acute Myocardial Infarction by Human Stemness Factors Induced Pluripotent Stem Cells
Author(s) -
Timothy J. Nelson,
Almudena MartinezFernandez,
Satsuki Yamada,
Carmen Pérez-Terzic,
Yasuhiro Ikeda,
André Terzic
Publication year - 2009
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.109.865154
Subject(s) - induced pluripotent stem cell , reprogramming , sox2 , embryonic stem cell , stem cell , klf4 , medicine , microbiology and biotechnology , regenerative medicine , biology , immunology , cell , genetics , gene
Nuclear reprogramming provides an emerging strategy to produce embryo-independent pluripotent stem cells from somatic tissue. Induced pluripotent stem cells (iPS) demonstrate aptitude for de novo cardiac differentiation, yet their potential for heart disease therapy has not been tested.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom